| Changes in medicare reimbursement: impact on therapy for benign prostatic hyperplasia. | |
| | |
MedLine Citation:
|
PMID: 12149158 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Medicare spending accounts for 17% of all health spending and therefore exerts a significant influence on health care spending policies. Medicare policies such as Diagnostic Related Groups and the Resource Based Relative Value System have resulted in profound changes in health care delivery in the United States. These resource-allocation methods are one of the major sources of controversies between managers, doctors, politicians, and social scientists. Financial disincentives associated with these resource-allocation policies have effectively rationed select therapies, particularly transurethral resection of the prostate (TURP). As a consequence, TURP, once the second most common surgical procedure billed to Medicare and comprising 38% of major surgical procedures performed by urologists, is increasingly challenged by medical therapy and minimally invasive surgical therapies that may be associated with lower efficacy and durability. This article examines the history of Medicare policies and their influence on TURP. |
| | |
Authors:
|
Robert F Donnell |
Related Documents
:
|
10348418 - Price competition and hospital cost growth in the united states (1989-1994). 10915458 - Individualizing medicare. 12079148 - Medicare's risk-adjusted capitation method. 17290628 - Estimating medicare advantage lock-in provisions impact on vulnerable medicare benefici... 15492788 - Reversal of multidrug-resistance using valspodar (psc 833) and doxorubicin in osteosarc... 15886798 - Does human semen contain a functional haemostatic system? a possible role for tissue fa... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current urology reports Volume: 3 ISSN: 1527-2737 ISO Abbreviation: Curr Urol Rep Publication Date: 2002 Aug |
Date Detail:
|
Created Date: 2002-07-31 Completed Date: 2002-10-02 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 100900943 Medline TA: Curr Urol Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 280-4 Citation Subset: IM |
Affiliation:
|
Division of Urology, The Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA. rdonnell@mcw.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Health Care Costs
/
trends Humans Insurance, Health, Reimbursement / economics, trends* Male Medicare / economics, trends* Prostatic Hyperplasia / economics*, therapy* Transurethral Resection of Prostate / economics United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ethanol injection for the treatment of benign prostatic hyperplasia.
Next Document: Phytotherapy for benign prostatic hyperplasia.